| 000 | 01015 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250515220835.0 | ||
| 264 | 0 | _c20100608 | |
| 008 | 201006s 0 0 eng d | ||
| 022 | _a1543-0790 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChintalgattu, Vishnu | |
| 245 | 0 | 0 |
_aReview: cardiovascular toxicities due to molecularly targeted cancer therapeutics. _h[electronic resource] |
| 260 |
_bClinical advances in hematology & oncology : H&O _cFeb 2010 |
||
| 300 |
_a133-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aCardiomyopathy, Dilated _xchemically induced |
| 650 | 0 | 4 |
_aCardiomyopathy, Hypertrophic _xchemically induced |
| 650 | 0 | 4 |
_aCardiotoxins _xadverse effects |
| 650 | 0 | 4 |
_aHeart Failure _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadverse effects |
| 700 | 1 | _aKhakoo, Aarif Y | |
| 773 | 0 |
_tClinical advances in hematology & oncology : H&O _gvol. 8 _gno. 2 _gp. 133-5 |
|
| 999 |
_c19745415 _d19745415 |
||